Systemic Sclerosis Associated Interstitial Lung Disease Ssc Ild clinical trials

Explore recruiting systemic sclerosis associated interstitial lung disease ssc ild clinical trials.

Recruiting systemic sclerosis associated interstitial lung disease ssc ild studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Systemic Sclerosis Associated Interstitial Lung Disease Ssc Ild trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

Exploratory, non-randomized, 3-group, microdosing clinical trial to investigate Gallium-68 (68Ga) labeled Platelet-Derived Growth Factor Beta (PDGFRß) targeting Positron Emission Tomography (PET) tracer (68Ga-ATH001) binding in the lungs in healthy participants versus participants with Systemic Sclerosis-associated Interstitial Lung Disease (SSc-ILD)

Sweden

Human Pharmacology (Phase I)- Other EU CTIS Study details

A Phase 2/3, randomized, double-blind, placebo-controlled, parallel-group study to evaluate the efficacy and safety of belimumab administered subcutaneously in adults with systemic sclerosis associated interstitial lung disease (SSc-ILD)

Germany, Greece, France, Finland, Denmark, Spain +2 more

Phase II and Phase III (Integrated) EU CTIS Study details

Systemic Sclerosis Associated Interstitial Lung Disease Ssc Ild trials by city

Systemic Sclerosis Associated Interstitial Lung Disease Ssc Ild in Toronto Systemic Sclerosis Associated Interstitial Lung Disease Ssc Ild in Vancouver Systemic Sclerosis Associated Interstitial Lung Disease Ssc Ild in Montreal Systemic Sclerosis Associated Interstitial Lung Disease Ssc Ild in Calgary Systemic Sclerosis Associated Interstitial Lung Disease Ssc Ild in Edmonton Systemic Sclerosis Associated Interstitial Lung Disease Ssc Ild in Ottawa Systemic Sclerosis Associated Interstitial Lung Disease Ssc Ild in Winnipeg Systemic Sclerosis Associated Interstitial Lung Disease Ssc Ild in Quebec City Systemic Sclerosis Associated Interstitial Lung Disease Ssc Ild in Hamilton Systemic Sclerosis Associated Interstitial Lung Disease Ssc Ild in Kitchener Systemic Sclerosis Associated Interstitial Lung Disease Ssc Ild in London Systemic Sclerosis Associated Interstitial Lung Disease Ssc Ild in Halifax Systemic Sclerosis Associated Interstitial Lung Disease Ssc Ild in New York Systemic Sclerosis Associated Interstitial Lung Disease Ssc Ild in Los Angeles Systemic Sclerosis Associated Interstitial Lung Disease Ssc Ild in Chicago Systemic Sclerosis Associated Interstitial Lung Disease Ssc Ild in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease